Lipoproteins and Cardiovascular Health
76 ta ish
Dynamics of immuno-inflammatory markers in patients with chronic heart failure after myocardial infarction during treatment with rosuvastatin
M. M. Abdurakhmanov, А. А. Хамраев, M.S. Radjabova
MaqolaCytokine Signaling Pathways and InteractionsAmerican Journal Of Biomedical Science & Pharmaceutical Innovation20250 iqtibosABIEASY OR NOT. European-Asian Six countries Yearly consensus On Recent guidelines: arterial hypertension, atrial fibrillation, chronic coronary syndromes, and peripheral artery diseases. Novel Or conventional Treatment options for these patients. Position Paper 2024
Krzysztof J. Filipiak, Matteo Cameli, Santiago J. Freire +9
ABITherapy After Percutaneous Coronary Intervention in Chronic Coronary Disease: A Practical Review for Internal Medicine and Interventional Cardiology
Akramov Bekhzod Bakhromjon o'gli
MaqolaLipoproteins and Cardiovascular HealthThe American Journal of Medical Sciences and Pharmaceutical Research20260 iqtibosABISTRATIFICATION OF PROATHEROGENIC POTENTIAL IN CHRONIC CORONARY SYNDROMES: SUPERIORITY OF APOLIPOPROTEIN B/A-I RATIO OVER TRADITIONAL LIPID METRICS IN THE UZBEK POPULATION
Sanskar Virmani, Rano Shavkatovna Rajabova
MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsZenodo (CERN European Organization for Nuclear Research)20260 iqtibosABI